Dr. Christian Robert Deutsch, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Whitesburg Dr Se Ste 201, Huntsville, AL 35802 Phone: 256-880-1050 Fax: 256-880-7477 |
Dr. Navdeep Kaur Mann, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 930 Franklin St Se, Huntsville, AL 35801 Phone: 256-539-4080 Fax: 256-539-4099 |
Dr. Carl John Gessler Jr., M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4810 Whitesport Cir Sw Ste 217, Huntsville, AL 35801 Phone: 256-489-5040 Fax: 256-489-5074 |
Joshusa D Valtos, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 930 Franklin St Se, Huntsville, AL 35801 Phone: 256-533-3388 Fax: 256-801-6905 |
Rashida Alyia Abbas, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 930 Franklin St Se, Huntsville, AL 35801 Phone: 256-539-4080 Fax: 256-539-4099 |
Dr. William J Schneider, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Whitesburg Dr Se, Suite 201, Huntsville, AL 35802 Phone: 256-880-1050 Fax: 256-213-4661 |
Dr. Sadasiva Rao Katta, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4700 Whitesburg Dr Se, Suite 200, Huntsville, AL 35802 Phone: 256-882-1450 Fax: 256-882-3823 |
Dr. Enrique Martin Velasquez, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 930 Franklin St Se, Huntsville, AL 35801 Phone: 256-539-4080 Fax: 256-539-4099 |
Jacqueline Lynn Green, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 930 Franklin St Se, Huntsville, AL 35801 Phone: 256-533-3388 Fax: 256-801-6905 |
News Archive
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).
Eating smart, not eating less, may be the key to losing weight. A year-long clinical trial by Penn State researchers shows that diets focusing on foods that are low in calorie density can promote healthy weight loss while helping people to control hunger.
Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair.
John E. Gerich, M.D., professor of Medicine and program director of the General Clinical Research Center at the University of Rochester Medical Center, has been awarded the Novartis Prize for Long-Standing Achievement in Diabetes.
› Verified 3 days ago